Excellence Backed by Experience
InSightec® is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.
ExAblate® is the first system to use the MR guided focused ultrasound technology. ExAblate received Euroopean CE mark in 2002 and the USA, Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. In June 2007, ExAblate received CE Mark for pain palliation of bone tumors and for the treatment of adenomyosis in June 2010. The FDA gave its post marketing approval in October 2012. In November 2012, ExAblate received the CE Mark for the treatment of three neurological disorders, Essential Tremors, Parkinso's and Neuropathic Pain.*
ExAblate, using MR guided Focused ultrasound, has won numerous innovation awards and has been used to treat thousands of patients around the world.
ExAblate® O.R. is a non-invasive Operating Room. The system incorporates interchangeable cradles for each application that are interfaced with the common table. ExAblate O.R. offers both commercially approved and research treatment options for a multitude of clinical indications such as: uterine fibroids and adenomyosis,pain palliation of bone metastases*, breast cancer, prostate cancer, and various other indications**.
ExAblate® Neuro is designed for the non-invasive treatment of various brain disorders, ExAblate Neuro is CE marked for the treatment of Essential Tremors, Parkinso's and Neuropathic Pain.
InSightec continues to innovate and research: click here for an update about ongoing pre-clinical and clinical research
* Not all applications are approved in all regions.
Please consult your local representatives and read the product labeling specific for your region to determine approved indications for use.
**Under clinical investigation
History of InSightec
InSightec was founded in 1999 when GE Healthcare (then GE Medical Systems) and Elbit Medical Imaging transferred their proprietary technology to the company to enable it to concentrate on developing the promising MR guided focused ultrasound surgery both companies had investigated. Since then, InSightec has invested over $150 million in research and development. The company holds over 90 patents with additional intellectual property pending.
The 120 InSightec staff includes world class scientists and engineers with extensive experience in the wide variety of disciplines involved with this enhanced technology and teamed with leading application specialists, manufacturing, service and other personnel. The company is headquartered in Tirat Carmel, Israel, near the port city of Haifa. Its US offices are in Milwaukee WI and Dallas, TX.
Around the world, physicians are treating patients every day with ExAblate, using focused ultrasound guided by MRI. Click here to find a treating center near you
Clinical ExAblate Partners
InSightec has established clinical collaborations with leading hospitals and medical research institutions around the world. Many of these sites participate in sponsored trials to gather clinical data that will advance the company’s technology and create an ever-widening spectrum of clinical applications.
InSightec Ltd. is a privately held company founded in 1999 and owned by Elbit Imaging, Elbit Medical Technologies, General Electric, MediTech Advisors, LLC and employees.
For more information please contact us.